Harrington Investments INC Decreases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Harrington Investments INC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 1.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 2,276 shares of the medical equipment provider’s stock after selling 22 shares during the quarter. Harrington Investments INC’s holdings in Intuitive Surgical were worth $1,188,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in ISRG. First National Trust Co lifted its stake in Intuitive Surgical by 7.7% in the 4th quarter. First National Trust Co now owns 13,913 shares of the medical equipment provider’s stock valued at $7,262,000 after buying an additional 994 shares in the last quarter. Midwest Professional Planners LTD. lifted its position in shares of Intuitive Surgical by 3.4% in the fourth quarter. Midwest Professional Planners LTD. now owns 3,033 shares of the medical equipment provider’s stock valued at $1,583,000 after acquiring an additional 100 shares in the last quarter. Renasant Bank boosted its stake in shares of Intuitive Surgical by 58.5% in the fourth quarter. Renasant Bank now owns 986 shares of the medical equipment provider’s stock worth $515,000 after acquiring an additional 364 shares during the last quarter. Atala Financial Inc acquired a new position in Intuitive Surgical in the 4th quarter valued at $25,000. Finally, LBP AM SA lifted its holdings in Intuitive Surgical by 90.2% in the 4th quarter. LBP AM SA now owns 63,804 shares of the medical equipment provider’s stock valued at $33,303,000 after purchasing an additional 30,258 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last three months. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Raymond James increased their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Citigroup increased their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Evercore ISI boosted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $613.10.

View Our Latest Report on ISRG

Intuitive Surgical Trading Up 1.6 %

ISRG stock opened at $484.44 on Friday. The business’s fifty day moving average price is $567.46 and its 200 day moving average price is $531.26. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market capitalization of $172.55 billion, a PE ratio of 75.58, a P/E/G ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.